Catalyst Wire Dossier Catalyst Wire Dossier

GLPG3121-modified Release Formulation

· Galapagos NV
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLPG3121-modified Release Formulation, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate How Well Single and Multiple Doses of GLPG3121-modified Release Formulation Are Tolerated in Healthy, Adult Subjects [Phase 1]

See pricing